UCB's Global Corporate Website
Welcome to UCB in the United States

May

06

Evolving Expectations for Arthritis Management

Nov

11

Post Hoc Analysis Showed CIMZIA® (Certolizumab Pegol) Resulted in Meaningful Efficacy for RA Patients with High Levels of Rheumatoid Factor (RF)